PURPOSE: To examine the benefit of using higher field strengths for BOLD MRI to detect changes in renal medullary oxygenation following pharmacological maneuvers. MATERIALS AND METHODS: Renal BOLD MRI, primarily at 1.5 T, has been shown to be useful for monitoring changes in medullary oxygenation status. We performed the present studies on a 3.0 T scanner using a multiple gradient-echo (mGRE) sequence with a multicoil array to acquire 16 T2*-weighted images within a single breath-hold. Data were obtained before and after administration of furosemide (20 mg iv). RESULTS: The baseline renal R2* (mean +/- SE) at 3.0 T was 37.4+/-1.2 Hz in the medulla, and 21.8 +/- 1.2 Hz in the cortex. The BOLD response to furosemide (DeltaR2*) at 3.0 T was 11.8 +/- 1.1 Hz in the medulla, and 3.0 +/- 0.5 Hz in the cortex. CONCLUSION: Higher magnetic field strength is beneficial for renal BOLD MRI studies. The cortico-medullary contrast on the R2* map was significantly improved at 3.0 T, with no evidence of increased bulk susceptibility artifacts. Baseline R2* and DeltaR2* in the renal medulla at 3.0 T were both significantly higher compared to our previously reported data obtained at 1.5 T.
PURPOSE: To examine the benefit of using higher field strengths for BOLD MRI to detect changes in renal medullary oxygenation following pharmacological maneuvers. MATERIALS AND METHODS: Renal BOLD MRI, primarily at 1.5 T, has been shown to be useful for monitoring changes in medullary oxygenation status. We performed the present studies on a 3.0 T scanner using a multiple gradient-echo (mGRE) sequence with a multicoil array to acquire 16 T2*-weighted images within a single breath-hold. Data were obtained before and after administration of furosemide (20 mg iv). RESULTS: The baseline renal R2* (mean +/- SE) at 3.0 T was 37.4+/-1.2 Hz in the medulla, and 21.8 +/- 1.2 Hz in the cortex. The BOLD response to furosemide (DeltaR2*) at 3.0 T was 11.8 +/- 1.1 Hz in the medulla, and 3.0 +/- 0.5 Hz in the cortex. CONCLUSION: Higher magnetic field strength is beneficial for renal BOLD MRI studies. The cortico-medullary contrast on the R2* map was significantly improved at 3.0 T, with no evidence of increased bulk susceptibility artifacts. Baseline R2* and DeltaR2* in the renal medulla at 3.0 T were both significantly higher compared to our previously reported data obtained at 1.5 T.
Authors: Monika L Gloviczki; James F Glockner; Lilach O Lerman; Michael A McKusick; Sanjay Misra; Joseph P Grande; Stephen C Textor Journal: Hypertension Date: 2010-03-01 Impact factor: 10.190
Authors: Jeff L Zhang; Glen Morrell; Henry Rusinek; Lizette Warner; Pierre-Hugues Vivier; Alfred K Cheung; Lilach O Lerman; Vivian S Lee Journal: Am J Physiol Renal Physiol Date: 2014-01-22
Authors: Stephen C Textor; James F Glockner; Lilach O Lerman; Sanjay Misra; Michael A McKusick; Stephen J Riederer; Joseph P Grande; S Ivan Gomez; J Carlos Romero Journal: J Am Soc Nephrol Date: 2008-02-20 Impact factor: 10.121